ProteaPex Therapeutics
BioTech/Drugs - Philadelphia, PA, US
ProteaPex Therapeutics Employees
ProteaPex Therapeutics Senior Management
ProteaPex Therapeutics Details
ProteaPex Therapeutics is working on research and development of the Extracellular Matrix Protection Factors (ECPFs). The ECPFs are a platform technology that can be tailored to several members of the Matrix Metalloprotease (MMP) family. The patented technology boasts development of potential therapeutics for indications in disease in which extracellular matrix degradation is hallmark such as periodontal disease (ECPF-2), osteoarthritis (ECPF-1), lung fibrosis (ECPF-3), cancer metastasis, wound healing and fracture non-union.
Website:
proteapextherapeutics.com
Employees:
5 - 9
HQ:
267-544-9799
Location:
Philadelphia, PA, US
Revenue:
Not Available
ProteaPex Therapeutics Technologies
Email Providers
Outlook
Load Balancers
Apache
Hosting
GoDaddy Hosting
Online Video Platforms
YouTube
Other
Mobile Friendly